John H. Halperna,,Correspondence information about the author John H. HalpernEmail the author John H. Halpern, Andrea R. Sherwoodc, James I. Hudsona, Deborah Yurgelun-Toddb, Harrison G. Pope Jra
Halpern, John H. et al.Biological Psychiatry, Volume 58, Issue 8, 624 – 631
Background
Hallucinogens are widely used, both by drug abusers and by peoples of traditional cultures who ingest these substances for religious or healing purposes. However, the long-term residual psychological and cognitive effects of hallucinogens remain poorly understood.
Methods
We recruited three groups of Navajo Native Americans, age 18–45: 1) 61 Native American Church members who regularly ingested peyote, a hallucinogen-containing cactus; 2) 36 individuals with past alcohol dependence, but currently sober at least 2 months; and 3) 79 individuals reporting minimal use of peyote, alcohol, or other substances. We administered a screening interview, the Rand Mental Health Inventory (RMHI), and ten standard neuropsychological tests of memory and attentional/executive functions.
Results
Compared to Navajos with minimal substance use, the peyote group showed no significant deficits on the RMHI or any neuropsychological measures, whereas the former alcoholic group showed significant deficits (p < .05) on every scale of the RMHI and on two neuropsychological measures. Within the peyote group, total lifetime peyote use was not significantly associated with neuropsychological performance.
Conclusions
We found no evidence of psychological or cognitive deficits among Native Americans using peyote regularly in a religious setting. It should be recognized, however, that these findings may not generalize to illicit hallucinogen users.
References
- IL; 1966
- Albaugh, B.J., Anderson, P.O. Peyote in the treatment of alcoholism among Native Americans. Am J Psychiatry. 1974;131:1247–1250
- American Indian Religious Freedom Act Amendments of 1994 (1994): 108 Statute 3124 Public Law 103-344. 42 USC.
- American Psychiatric Association. in: Diagnostic and Statistical Manual of Mental Disorders. 4th ed. American Psychiatric Press, Washington, DC; 1994
- Bergman, R.L. Navajo peyote use (Its apparent safety) . Am J Psychiatry. 1971;128:695–699
- Blum, K., Futterman, S.L., Pascarosa, P. Peyote, a potential ethnopharmacologic agent for alcoholism and other drug dependencies (Possible biochemical rationale) . Clin Toxicol. 1977;11:459–472
- Burke, H.R. Raven’s Progressive Matrices (More on norms, reliability, and validity) . J Clin Psychol. 1985;41:231–235
- Calabrese, J.D. Spiritual healing and human development in the Native American Church (Toward a cultural psychiatry of peyote) . Psychoanal Rev. 1997;84:237–255
- Davies, A.R., Sherbourne, C.D., Peterson, J.R., Ware, J.E. Scoring Manual. RAND Corporation, Santa Monica, CA; 1988
- de Rios, M.D., Grob, C.S., Baker, J.R. Hallucinogens and redemption. J Psychoactive Drugs. 2002;34:239–248
- Garrity, J.F. Jesus, peyote, and the holy people (Alcohol abuse and the ethos of power in Navajo healing) . Med Anthropol Q. 2000;14:521–542
- Glick, S.D., Maisonneuve, I.M. Development of novel medications for drug addiction. The legacy of an African shrub. Ann N Y Acad Sci. 2000;909:88–103
- Grant, I. Alcohol and the brain (Neuropsychological correlates) . J Consult Clin Psychol. 1987;55:310–324
- Grinspoon, L., Bakalar, J.B. Psychedelic Drugs Reconsidered. The Lindesmith Center, New York; 1997
- Grob, C.S. Psychiatric research with hallucinogens (What have we learned?) . Yearbook for Ethnomedicine and the Study of Consciousness. 1994;3:91–112
- Halpern, J.H. The use of hallucinogens in the treatment of addiction. Addict Res. 1996;4:177–189
- Halpern, J.H., Pope, H.G. Do hallucinogens cause residual neuropsychological toxicity?. Drug Alcohol Depend. 1999;53:247–256
- Halpern, J.H., Pope, H.G. Hallucinogen persisting perception disorder (What do we know after 50 years?) . Drug Alcohol Depend. 2003;69:109–119
- Halpern, J.H., Pope, H.G., Sherwood, A.R., Barry, S., Hudson, J.I., Yurgelun-Todd, D. Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs. Drug Alcohol Depend. 2004;75:135–147
- Heaton, R. Wisconsin Card Sorting Test Manual. Psychological Assessment Resources, Odessa, FL; 1981
- Hollister, L.E., Sjoberg, B.M. Clinical syndromes and biochemical alterations following mescaline, lysergic acid diethylamide, psilocybin, and a combination of the three psychomimetic drugs. Compr Psychiatry. 1964;20:170–178
- Jastak Associates. Wide Range Achievement Test, Revision 3. ; 1993 (Division of Wide Range, 15 Ashley Place, Suite 1A, Wilmington, DE 19804-1314.)
- Johnston, L.D., O’Malley, P.M., Bachman, J.G. Monitoring the Future national results on adolescent drug use. National Institute on Drug Abuse, Bethesda, MD; 2003
- La Barre, W. in: The Peyote Cult. 5th ed. University of Oklahoma Press, Tulsa; 1989
- Lamarine, R.J. Alcohol abuse among Native Americans. J Community Health. 1988;13:143–155
- MacLeod, C. Half a century of research on the Stroop effect (An integrative review) . Psychol Bull. 1991;109:163–203
- Mail, P.D., Johnson, S. Boozing, sniffing, and toking (An overview of the past, present, and future of substance use by American Indians) . Am Indian Alsk Native Ment Health Res. 1993;5:1–33
- Manson, S., Shore, J., Baron, A., Ackerson, L., Neligh, G. Alcohol abuse and dependence among American Indians. in: J.E. Helzer, G.J. Canino (Eds.) Alcoholism in North America, Europe, and Asia. Oxford University Press, New York; 1992:119–130
- Menninger, K. Discussion of Bergman RL (1971): Navajo peyote use: Its apparent safety. (Am J Psychiatry 128:695-699)Am J Psychiatry. 1971;128:699
- Nichols, D.E. Hallucinogens. Pharmacol Ther. 2004;101:131–181
- Nichols, D.E., Pfister, W.R., Yim, G.K.W., Cosgrove, R.J. A new view of the structural relationship between LSD and mescaline. Brain Res Bull. 1977;2:169–171
- Osterrieth, P. Le test de copie d’une figure complexe. Archives de Psychologie. 1944;30:206–356
- Parrott, A.C. Human psychopharmacology of Ecstasy (MDMA) (A review of 15 years of empirical research) . Hum Psychopharmacol. 2001;16:557–577
- Pope, H.G. Cannabis, cognition, and residual confounding. JAMA. 2002;287:1172–1174
- Pope, H.G., Gruber, A.J., Hudson, J.I., Huestis, M.A., Yurgelun-Todd, D. Neuropsychological performance in long-term cannabis users. Arch Gen Psychiatry. 2001;58:909–915
- Pope, H.G., Gruber, A.J., Yurgelun-Todd, D. Residual neuropsychological effects of cannabis. Curr Psychiatry Rep. 2001;3:507–512
- Reitan, R., Wolfson, D. The Halstead-Reitan Neuropsychological Test Battery (Theory and Clinical Interpretation) . 2nd ed. Neuropsychology Press, Tuson, AZ; 1993
- Roy, C. Indian peyotists and alcohol. (letter to the editor)Am J Psychiatry. 1973;130:329–330
- Shulgin, A.T., Sargent, T., Naranjo, C. Structure–activity relationships of one-ring psychotomimetics. Nature. 1969;221:537–541
- Slotkin, J.S. in: The Peyote Religion. 1st ed. The Free Press, Glencoe, IL; 1956
- Snyder, S.H., Merril, C.R. A quantum-chemical correlate of hallucinogenesis. in: H.E. Himwich, S.S. Kety, J.R. Smythies (Eds.) Amines and Schizophrenia. Pergamon Press, Oxford; 1967:229–245
- Stewart, O. Peyote Religion (A History) . 1st ed. University of Oklahoma Press, Tulsa; 1987
- Stroop, J. Studies of interference in serial verbal reactions. J Exp Psychol. 1935;18:643–662
- Veit, C.T., Ware, J.E. The structure of psychological distress and well-being in general populations. J Consult Clin Psychol. 1983;51:730–742
- Wechsler, D. A standardized memory scale for clinical use. J Clin Psychol. 1945;19:87–95
- Wechsler, D. Wechsler Adult Intelligence Scale-Revised Manual. Psychological Corp, Cleveland, OH; 1981